[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].

Saved in:
Bibliographic Details
Title: [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
Transliterated Title: Efectividad y seguridad del fingolimod en la practica clinica habitual en pacientes con esclerosis multiple remitente recurrente en España: analisis intermedio del estudio MS NEXT.
Authors: Mallada-Frechin J; Hospital General de Elda, 03600 Elda, Espana., Meca-Lallana V; Hospital Universitario de la Princesa, 28006 Madrid, Espana., Barrero F; Hospital Clinico Universitario San Cecilio, 18012 Granada, Espana., Martinez-Gines ML; Hospital General Universitario Gregorio Maranon, Madrid, Espana., Marzo-Sola ME; Complejo Hospitalario San Millan-San Pedro, 26004 Logrono, Espana., Ricart J; Novartis Farmaceutica, Barcelona, Espana., Garcia E; Novartis Farmaceutica, Barcelona, Espana., En Representacion de Los Investigadores Del Estudio Ms Next ERLIDEMN
Source: Revista de neurologia [Rev Neurol] 2018 Sep 01; Vol. 67 (5), pp. 157-167.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: IMR Press Country of Publication: Singapore NLM ID: 7706841 Publication Model: Print Cited Medium: Internet ISSN: 1576-6578 (Electronic) Linking ISSN: 02100010 NLM ISO Abbreviation: Rev Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1576-6578